Literature DB >> 17826323

Assessment of myocardial perfusion by dynamic O-15-labeled water PET imaging: validation of a new fast factor analysis.

Itaru Adachi1, Oliver Gaemperli, Ines Valenta, Tiziano Schepis, Patrick T Siegrist, Valerie Treyer, Cyrill Burger, Koichi Morita, Philipp A Kaufmann.   

Abstract

BACKGROUND: Factor analysis (FA) is an established method for separating myocardium from blood pool by use of oxygen 15-labeled water and positron emission tomography for analyzing myocardial blood flow (MBF). Conventional FA methods generating images from sinograms (sinoFA) are time-consuming, whereas FA can be performed on the reconstructed images (reconFA) in a fraction of time. We validated the MBF values obtained by reconFA versus sinoFA. METHODS AND
RESULTS: In 23 volunteers (mean age, 26.6 +/- 3.4 years) MBF was calculated from sinoFA and reconFA and blindly reanalyzed 1 month later by the same observer. Intraobserver agreement and reconFA-versus-sinoFA agreement were assessed according to Bland and Altman (BA). Reproducibility proved excellent for global sinoFA (r = 0.968; P < .001; BA limits, -0.617 to 0.676 mL x min(-1) x g(-1)) and slightly superior for reconFA (r = 0.979; P < .001; BA limits, -0.538 to 0.558 mL x min(-1) x g(-1)), with wider limits of agreement for segmental MBF from sinoFA (r = 0.777; P < .001; BA limits, -1.676 to 1.656 mL x min(-1) x g(-1)) and reconFA (r = 0.844; P < .001; BA limits, -1.999 to 1.992 mL x min(-1) x g(-1)). In addition, sinoFA and reconFA showed excellent correlation (r = 0.975, P < .001) and agreement (BA limits, -0.528 to 0.648 mL x min(-1) x g(-1)) for global and segmental values (r = 0.955; P < .001; BA limits, -1.371 to 1.491 mL x min(-1) x g(-1)).
CONCLUSIONS: Use of reconFA allows rapid and reliable quantitative MBF assessment with O-15-labeled water.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17826323     DOI: 10.1016/j.nuclcard.2007.05.012

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  23 in total

Review 1.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

2.  Reproducibility of measurements of regional myocardial blood flow in a model of coronary artery disease: Comparison of H215O and 13NH3 PET techniques.

Authors:  Panithaya Chareonthaitawee; Stuart D Christenson; Jill L Anderson; Brad J Kemp; David O Hodge; Erik L Ritman; Raymond J Gibbons
Journal:  J Nucl Med       Date:  2006-07       Impact factor: 10.057

3.  Generation of parametric image of regional myocardial blood flow using H(2)(15)O dynamic PET and a linear least-squares method.

Authors:  Jae Sung Lee; Dong Soo Lee; Ji Young Ahn; Jeong Seok Yeo; Gi Jeong Cheon; Seok-Ki Kim; Kwang Suk Park; June-Key Chung; Myung Chul Lee
Journal:  J Nucl Med       Date:  2005-10       Impact factor: 10.057

4.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

5.  Assessment of the reproducibility of baseline and hyperemic myocardial blood flow measurements with 15O-labeled water and PET.

Authors:  P A Kaufmann; T Gnecchi-Ruscone; J T Yap; O Rimoldi; P G Camici
Journal:  J Nucl Med       Date:  1999-11       Impact factor: 10.057

6.  Smoking cessation normalizes coronary endothelial vasomotor response assessed with 15O-water and PET in healthy young smokers.

Authors:  Koichi Morita; Takahiro Tsukamoto; Masanao Naya; Kazuyuki Noriyasu; Masayuki Inubushi; Tohru Shiga; Chietsugu Katoh; Yuji Kuge; Hiroyuki Tsutsui; Nagara Tamaki
Journal:  J Nucl Med       Date:  2006-12       Impact factor: 10.057

7.  Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans.

Authors:  P Chareonthaitawee; P A Kaufmann; O Rimoldi; P G Camici
Journal:  Cardiovasc Res       Date:  2001-04       Impact factor: 10.787

8.  Quantification of regional myocardial blood flow in vivo with H215O.

Authors:  S R Bergmann; K A Fox; A L Rand; K D McElvany; M J Welch; J Markham; B E Sobel
Journal:  Circulation       Date:  1984-10       Impact factor: 29.690

9.  Generation of myocardial factor images directly from the dynamic oxygen-15-water scan without use of an oxygen-15-carbon monoxide blood-pool scan.

Authors:  F Hermansen; J Ashburner; T J Spinks; J S Kooner; P G Camici; A A Lammertsma
Journal:  J Nucl Med       Date:  1998-10       Impact factor: 10.057

10.  Tetrahydrobiopterin restores impaired coronary microvascular dysfunction in hypercholesterolaemia.

Authors:  Christophe A Wyss; Pascal Koepfli; Mehdi Namdar; Patrick T Siegrist; Thomas F Luscher; Paolo G Camici; Philipp A Kaufmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-31       Impact factor: 9.236

View more
  8 in total

1.  Intra- and inter-operator repeatability of myocardial blood flow and myocardial flow reserve measurements using rubidium-82 pet and a highly automated analysis program.

Authors:  Ran Klein; Jennifer M Renaud; Maria C Ziadi; Stephanie L Thorn; Andy Adler; Rob S Beanlands; Robert A deKemp
Journal:  J Nucl Cardiol       Date:  2010-04-13       Impact factor: 5.952

2.  15-O-water myocardial flow reserve PET and CT angiography by full hybrid PET/CT as a potential alternative to invasive angiography.

Authors:  Anders Thomassen; Poul-Erik Braad; Kasper T Pedersen; Henrik Petersen; Allan Johansen; Axel C P Diederichsen; Hans Mickley; Lisette O Jensen; Juhani Knuuti; Oke Gerke; Poul F Høilund-Carlsen
Journal:  Int J Cardiovasc Imaging       Date:  2018-07-31       Impact factor: 2.357

3.  Quantification of myocardial blood flow with 82Rb positron emission tomography: clinical validation with 15O-water.

Authors:  John O Prior; Gilles Allenbach; Ines Valenta; Marek Kosinski; Cyrill Burger; Francis R Verdun; Angelika Bischof Delaloye; Philipp A Kaufmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-03-08       Impact factor: 9.236

4.  Coronary calcium score scans for attenuation correction of quantitative PET/CT 13N-ammonia myocardial perfusion imaging.

Authors:  Nina Burkhard; Bernhard A Herzog; Lars Husmann; Aju P Pazhenkottil; Irene A Burger; Ronny R Buechel; Ines Valenta; Christophe A Wyss; Philipp A Kaufmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-23       Impact factor: 9.236

Review 5.  Advanced tracers in PET imaging of cardiovascular disease.

Authors:  Yesen Li; Wei Zhang; Hua Wu; Gang Liu
Journal:  Biomed Res Int       Date:  2014-10-15       Impact factor: 3.411

6.  Multimodality quantitative assessments of myocardial perfusion using dynamic contrast enhanced magnetic resonance and 15O-labelled water positron emission tomography imaging.

Authors:  G Papanastasiou; M C Williams; M R Dweck; S Mirsadraee; N Weir; A Fletcher; C Lucatelli; D Patel; E J R van Beek; D E Newby; S I K Semple
Journal:  IEEE Trans Radiat Plasma Med Sci       Date:  2018-01-23

Review 7.  SPECT and PET imaging of angiogenesis and arteriogenesis in pre-clinical models of myocardial ischemia and peripheral vascular disease.

Authors:  Geert Hendrikx; Stefan Vöö; Matthias Bauwens; Mark J Post; Felix M Mottaghy
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-08-12       Impact factor: 9.236

8.  Simultaneous 13N-Ammonia and gadolinium first-pass myocardial perfusion with quantitative hybrid PET-MR imaging: a phantom and clinical feasibility study.

Authors:  Muhummad Sohaib Nazir; Sarah-May Gould; Xenios Milidonis; Eliana Reyes; Tevfik F Ismail; Radhouene Neji; Sébastien Roujol; Jim O'Doherty; Hui Xue; Sally F Barrington; Tobias Schaeffter; Reza Razavi; Paul Marsden; Peter Kellman; Sven Plein; Amedeo Chiribiri
Journal:  Eur J Hybrid Imaging       Date:  2019-09-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.